The full $8M from the SPA is now raised, removing near-term capital raise uncertainty but adding convertible and warrant overhang. Monitor the next 10-Q for conversion activity, warrant exercises, and use of proceeds. The reverse split suggests the stock was trading at very low levels; further dilution could pressure the post-split price.
Price Chart
Executive Summary
SRX Global Inc. completed the final closing of its previously announced $8.0 million private placement, raising $3.472 million through the issuance of 4,340 Series B convertible preferred shares and 284,156 warrants (post-60:1 reverse split). This closes out the Securities Purchase Agreement from March 2026, providing the company with full proceeds but adding convertible and warrant overhang to a $35M market cap stock.
Key Financial Metrics
Key Facts
- Additional closing on July 27, 2026 raised $3.472 million from accredited investors.
- Issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants to purchase common stock.
- Securities were sold in a private placement exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.
- Warrant count reflects adjustment for the 60-for-1 reverse stock split effective July 2, 2026.
- This closing completes the $8.0 million Securities Purchase Agreement originally announced March 16, 2026.
Financial Impact
Proceeds of $3.472 million represent approximately 9.9% of the $35M market cap. Potential dilution from conversion of Series B preferred and exercise of warrants is material but unquantifiable without conversion/exercise terms.
Risk Factors
- Significant potential dilution from conversion of Series B preferred shares and exercise of warrants.
- Reverse stock split indicates prior low stock price and potential for continued volatility.
- Company has a history of name changes (formerly SRx Health Solutions, Better Choice Co Inc., Sport Endurance), suggesting restructuring risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (SRXH) — Batch item 1 | 0001493152-26-034950 |
| Document: 0001493152-26-034950-index-headers.html | 0001493152-26-034950 |
| Document: 0001493152-26-034950-index.html | 0001493152-26-034950 |
| Document: 0001493152-26-034950.txt | 0001493152-26-034950 |
| 8-K Filing (SRXH) — Batch item 5 | 0001493152-26-034950 |
| Document: 0001493152-26-034950-index-headers.html | 0001493152-26-034950 |
| Document: 0001493152-26-034950-index.html | 0001493152-26-034950 |
| Document: 0001493152-26-034950.txt | 0001493152-26-034950 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $1.51 $1.60 | ▲ +5.96% | ▲ +6.62% | $1.61 (+6.62%) |
Sep 2, 2026 4w ago | 8-K | $1.56 $1.59 | ▲ +1.92% | ▲ +3.07% | $1.61 (+3.21%) |
Aug 28, 2026 5w ago | 8-K | $1.68 $1.59 | ▲ +5.65% | ▲ +5.51% | $1.61 (+4.17%) |
Aug 19, 2026 6w ago | 8-K | $1.87 $1.84 | ▼ −1.60% | ▼ −1.22% | $1.61 (−13.90%) |
Aug 4, 2026 8w ago | Press Release | $1.37 $1.84 | ▲ +34.31% | ▲ +34.41% | $1.61 (+17.52%) |
Aug 3, 2026 8w ago | Press Release | $1.44 $1.73 | ▲ +20.14% | ▲ +18.11% | $1.61 (+11.81%) |
Jul 30, 2026 9w ago | Press Release | $1.48 $1.43 | ▼ −3.38% | ▼ −7.00% | $1.61 (+8.78%) |
Jul 28, 2026 9w ago | 8-K | $1.48 $1.44 | ▲ +2.70% | ▲ +4.97% | $1.61 (−8.78%) |
Jul 16, 2026 11w ago | 8-K | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
Jul 16, 2026 11w ago | Press Release | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access